世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の再生医療市場

Global Regenerative Medicines Market

 

出版社 出版年月電子版価格 ページ数
Market Litmus
マーケットリトマス
2018年5月US$3,850
シングルユーザライセンス
230

サマリー

この調査レポートは世界の再生医療市場詳細に調査・分析したMarket Litmusの市場調査報告書です。

Overview

By 2022, the Global Regenerative Medicines Market is estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period.Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals withthe repair, replacement, and regeneration of tissues and organs affected due to injury, disease, or natural ageing process.These medicines are capable of restoring the functionality of cells & tissues and encompass a wide range of degenerative disorders such as dermatology, cardiovascular, and neurodegenerative diseases. Some of the biomedical approaches within the field of regenerative medicineinvolve the use of stem cells owing to their ability to proliferate and differentiate. The regenerative medicine market shows immense potential for growth, finding solutions to some of the most challenging medical problems faced by humankind.

Market Dynamics

A rapidly rising prevalence of chronic diseases and trauma emergencies, boost in government funding for R&D, and an increased focus of vendors to develop cell therapy productsare the key factors propelling the growth of the regenerative medicines market.Regenerative productsare also surging due to an increasing awareness among people coupled with the technological advancements in stem cell therapy and tissue engineering. Moreover, the utilization of nanomaterials in wound care, immunomodulation, and drug delivery has further opened growth avenues for the market.

Conversely, stringent regulatory barriers, ethical issues related to regenerative medicines, and the high cost of the treatment are likely to hinder the market growth.

Market Segmentation

The global regenerative medicines market is fragmented on the basis oftype, technology, and applications.

Type

--> Cell-based Products

--> Acellular Products

Technology

--> Stem Cell Therapy

--> Biomaterial

--> Tissue Engineering

Applications

--> Orthopedic

--> Musculoskeletal Disorders

--> Dermatology

--> Cardiology

--> Diabetes

--> Central Nervous System Diseases

Geographical Analysis

The North American market is by far the largest in the regenerative medicines industry and is expected to continue its dominance across the globe due to increasing end-use applications in the region.The European Market, segmented into the United Kingdom, Germany, France, Italy, Spain, and rest of Europe, is the second leading market for regenerative medicine. The Asia Pacific regional market is also expected to witness a significant growth in the near future, mainly due to technological advancements, favourable reimbursement policies, and increased government funding.

Key Players

Some of the prominent companies dominating the global regenerative medicines market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.), and Medtronic (Ireland).Vendors are adopting product enhancements and launches, acquisitions, and agreements as their key business strategies in order to top the global market. Competition in the market is anticipated to further intensify during the forecast period with an increase in product extensions and technological innovations.

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage



目次

目次はデータリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る